CountryVietnam
Pharmaceuticals
Distributor Identification

Distributor Identification for Pharmaceuticals in Vietnam

Vietnam's pharmaceutical market is growing rapidly but navigating MOH licensing requirements, cold-chain logistics, and a fragmented distributor landscape demands local intelligence. Taevas Global identifies, profiles, and validates compliant distribution

Request Proposal
Market
Vietnam
Industry
Pharmaceuticals
Service
Distributor Identification
Regulator
Drug Administration of Vietnam (DAV), MOH Vietnam
Timeline
4-6 weeks
What We Deliver

Six Pillars of Vietnam Pharmaceuticals Intelligence

Our distributor identification framework covers every dimension that determines whether a distribution partnership will survive regulatory scrutiny and deliver commercial results in Vietnam.

01

Distributor Landscape Mapping

We systematically catalogue every licensed pharmaceutical distributor operating in Vietnam, segmenting them by therapeutic focus, geographic reach, and GDP-compliant storage capability. This gives you a complete, unbiased view of the addressable partner universe before any outreach begins.

Full registry of DAV-licensed distributors by province
Segmentation by therapeutic category and channel type
Cold-chain and GDP certification status for each entity
How It Works

From Brief to Board-Ready Intelligence

Our four-stage engagement is designed to move quickly without sacrificing the depth that pharmaceutical market entry in Vietnam demands.

Step 1 · Day 1-2

Intake and Scoping

We conduct a structured intake session to capture your product portfolio, target therapeutic areas, preferred channel mix, and any existing Vietnam relationships. This brief shapes every subsequent research decision and prevents wasted effort on irrelevant distributor profiles.

Taevas Approach

The intake session covers product registration status with DAV, pricing strategy, target hospital vs pharmacy channel split, preferred exclusivity model, and any geographic priorities within Vietnam such as Ho Chi Minh City, Hanoi, or secondary cities. We also review any existing MOH correspondence or prior distributor contacts you may have.

Market Snapshot

Vietnam Pharmaceuticals Market at a Glance

$0B+
Pharmaceutical Market Size (2023)
0%
Projected Annual Growth Rate
0+
Licensed Pharmaceutical Distributors
0+
Drug Registrations on DAV Record

Fragmented Distribution Landscape

Vietnam's pharmaceutical distribution market is dominated by a small number of large national distributors such as Zuellig Pharma and DKSH, but the majority of the market is served by dozens of regional and provincial distributors with limited national reach. Foreign manufacturers must carefully match their distribution partner to their channel strategy, as no single distributor covers all 63 provinces with equal depth.

Strict DAV Licensing Requirements

The Drug Administration of Vietnam requires all pharmaceutical distributors to hold a valid GDP certificate and a distribution business licence under Decree 54/2017/ND-CP and its amendments. Foreign manufacturers are not permitted to distribute directly and must appoint a licensed local entity as the Marketing Authorisation Holder or authorised importer, making distributor selection a regulatory as much as a commercial decision.

Hospital Tender Channel Dominance

Approximately 70 percent of pharmaceutical sales in Vietnam flow through the public hospital tender system, which is governed by Circular 15/2019/TT-BYT and administered at provincial level. Distributors with strong relationships with provincial health departments and a track record of successful tender bids are disproportionately valuable partners for ethical pharmaceutical manufacturers.

Rising Demand for Innovative Medicines

Vietnam's growing middle class, increasing non-communicable disease burden, and government investment in universal health coverage are driving demand for innovative branded medicines, biologics, and oncology products. The government's Industry Pharmaceutical Development Strategy to 2030 explicitly targets increasing the proportion of domestically produced and imported innovative drugs, creating a favourable environment for foreign pharmaceutical manufacturers.

What's Included

Everything in Your Report

The Distributor Identification report for Vietnam Pharmaceuticals is a single, self-contained deliverable that gives your team everything needed to make a confident partner decision.

Vietnam Distributor Market Overview

A structured overview of the pharmaceutical distribution landscape in Vietnam, covering market structure, key player categories, and channel dynamics across hospital, pharmacy, and private clinic segments.

Regulatory Compliance Summary

A plain-language summary of DAV and MOH requirements governing pharmaceutical distribution, including GDP certification, import agent registration, and Marketing Authorisation Holder obligations under current Vietnamese law.

Long List of Candidate Distributors

A fully researched long list of DAV-licensed distributors meeting your minimum criteria, with standardised profiles covering licence status, therapeutic focus, geographic footprint, and channel specialisation.

Regulatory and Compliance Scorecards

Individual compliance scorecards for each shortlisted distributor, assessing GDP certification, enforcement history, MAH capability, and alignment with your product registration pathway.

Geographic Coverage Maps

Visual maps illustrating each shortlisted distributor's provincial coverage, warehouse locations, and hospital tender participation across Vietnam's key regions.

Ranked Shortlist with Full Profiles

A ranked shortlist of three to five distributors, each with a comprehensive profile covering commercial capability, financial indicators, principal portfolio, key contacts, and Taevas Global's strategic recommendation.

Risk and Red Flag Analysis

A dedicated risk section identifying compliance gaps, exclusivity conflicts, financial vulnerabilities, and reputational concerns for each shortlisted distributor, with recommended mitigation strategies.

Outreach and Negotiation Guidance

Practical guidance on outreach sequencing, suggested term sheet parameters, key negotiation leverage points, and common contractual pitfalls under Vietnamese distribution law.

Who This Is For

Built for These Situations

First-Time Market Entry

Pharmaceutical Manufacturer Entering Vietnam for the First Time

You have a product registered or in registration with DAV and need to identify a qualified local distribution partner before your licence is granted. You have limited existing relationships in Vietnam and need an objective, research-driven view of the distributor landscape rather than relying on unsolicited approaches from distributors of unknown quality.

Outcome
A ranked shortlist of DAV-compliant distributors aligned to your therapeutic area, channel strategy, and geographic priorities, delivered before your registration milestone so you can execute immediately upon approval.
FAQ

Common Questions

Get Started

Ready to Map Your Vietnam Opportunity?

Identify the right pharmaceutical distribution partner in Vietnam with research-backed intelligence, regulatory expertise, and local market knowledge from Taevas Global.

DAV-compliant distributor shortlist delivered in 4-6 weeks
Vietnam-based research team with pharmaceutical sector expertise
Regulatory compliance screening built into every candidate profile
Optional warm introductions to shortlisted distribution partners